EdgarLookup

Zenas BioPharma, Inc. — All Filings

153 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-Q 3 4 4/A 424B4 424B5 424B7 8-A12B 8-K ARS CERT CORRESP D DEF 14A DEFA14A DRS DRS/A DRSLTR EFFECT FWP S-1 S-1/A S-1MEF S-3ASR S-8 SC 13D SC 13G SCHEDULE 13D SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A SEC STAFF LETTER UPLOAD
Form Description Accession Number Filed Period
FWP FWP 0001104659-26-035494 Mar 27, 2026
FWP FWP 0001104659-26-035475 Mar 27, 2026
424B5 424B5 0001104659-26-035241 Mar 26, 2026
424B5 424B5 0001104659-26-035237 Mar 26, 2026
FWP FWP 0001104659-26-035203 Mar 26, 2026
DEFA14A DEFA14A 0001104659-26-028064 Mar 16, 2026
ARS ARS 0001104659-26-028063 Mar 16, 2026 Dec 31, 2025
DEF 14A DEF 14A 0001104659-26-028062 Mar 16, 2026 May 11, 2026
S-8 FORM S-8 0001104659-26-027991 Mar 16, 2026
10-K 10-K 0001104659-26-027964 Mar 16, 2026 Dec 31, 2025
8-K FORM 8-K 0001104659-26-027961 Mar 16, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-015387 Feb 13, 2026 Feb 11, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-015342 Feb 13, 2026 Feb 12, 2026
8-K FORM 8-K 0001104659-26-015314 Feb 13, 2026 Feb 10, 2026
SCHEDULE 13G/A 0000315066-26-000571 Feb 5, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-009756 Feb 3, 2026 Feb 2, 2026
424B7 424B7 0001104659-26-007414 Jan 28, 2026
SCHEDULE 13D 0001104659-26-003758 Jan 14, 2026
4 OWNERSHIP DOCUMENT 0001104659-26-002589 Jan 9, 2026 Jan 7, 2026
8-K FORM 8-K 0001104659-26-000402 Jan 5, 2026
S-8 FORM S-8 0001104659-25-123261 Dec 19, 2025
8-K FORM 8-K 0001104659-25-121182 Dec 15, 2025 Dec 10, 2025
SCHEDULE 13G/A 0001388325-25-000027 Nov 14, 2025
10-Q 10-Q 0001104659-25-109753 Nov 12, 2025 Sep 30, 2025
8-K FORM 8-K 0001104659-25-109737 Nov 12, 2025
8-K FORM 8-K 0001104659-25-102317 Oct 27, 2025
S-3ASR S-3ASR 0001104659-25-101271 Oct 21, 2025
3 0001213900-25-098960 Oct 15, 2025 Oct 7, 2025
SCHEDULE 13G 0001213900-25-098959 Oct 15, 2025
SCHEDULE 13D/A 0001953107-25-000010 Oct 14, 2025
SCHEDULE 13D/A 0001193125-25-239173 Oct 14, 2025
4 4 0001193125-25-239158 Oct 14, 2025 Oct 9, 2025
4 4 0001193125-25-239153 Oct 14, 2025 Oct 9, 2025
SCHEDULE 13D/A 0001193125-25-238370 Oct 14, 2025
4 4 0001193125-25-238326 Oct 14, 2025 Oct 9, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-098413 Oct 9, 2025 Oct 7, 2025
SCHEDULE 13D/A 0001104659-25-098408 Oct 9, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-098362 Oct 9, 2025 Oct 7, 2025
4 0000919574-25-006031 Oct 9, 2025 Sep 13, 2024
S-3ASR S-3ASR 0001104659-25-097950 Oct 8, 2025
8-K FORM 8-K 0001104659-25-097663 Oct 8, 2025 Oct 7, 2025
SCHEDULE 13G/A 0000315066-25-002257 Sep 8, 2025
8-K FORM 8-K 0001104659-25-085982 Sep 2, 2025
S-8 FORM S-8 0001104659-25-076498 Aug 12, 2025
10-Q 10-Q 0001558370-25-011147 Aug 12, 2025 Jun 30, 2025
8-K FORM 8-K 0001104659-25-076464 Aug 12, 2025
SCHEDULE 13G/A 0000315066-25-002136 Aug 6, 2025
4 4 0000950170-25-085531 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058943 Jun 12, 2025 Jun 10, 2025
4 OWNERSHIP DOCUMENT 0001104659-25-058940 Jun 12, 2025 Jun 10, 2025